Vivo Capital Surplus Fund VIII, L.P.
CIK 1628048 · last filed 2024-04-03
Vivo Capital Surplus Fund VIII, L.P. is a corporate insider who has filed 7 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing shows the insider sold $14.0M of TERN on Apr 3, 2024. Across all open-market trades the lifetime net is +$44.2M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $23.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$23.01M
3
7
$44.19M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Terns Pharmaceuticals, Inc. (TERN) Delisted | 10%+ Owner | 275,772 | $52.95 | $14.60M | -$3.18M | 2 | 2024-04-03 |
| ALGS | 10%+ Owner | 2,409,337 | $5.28 | $12.72M | $24.75M | 1 | 2020-10-20 |
| CRNX | 10%+ Owner | 298,625 | $34.47 | $10.29M | $22.62M | 4 | 2020-04-17 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-04-03 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Sell (S) | −2,103,315 | -$13.98M | EDGAR |
| 2022-09-08 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Buy (P) | +3,000,000 | $10.80M | EDGAR |
| 2020-10-20 | ALGS | Mixed | +10,641,090 | $24.75M | EDGAR |
| 2020-04-17 | CRNX | Sell (S) | −991,794 | -$15.32M | EDGAR |
| 2020-03-11 | CRNX | Sell (S) | −2,640 | -$51.5K | EDGAR |
| 2020-02-11 | CRNX | Sell (S) | −67,300 | -$1.46M | EDGAR |
| 2018-07-20 | CRNX | Mixed | +22,424,748 | $39.45M | EDGAR |